Navigation Links
Med Discovery and Laborium Biopharma Sign a Bioprocess Development Partnership Agreement
Date:11/19/2008

Med Discovery S.A., a Swiss biotech firm and Laborium Biopharma, a subsidiary of Validapro Biosciences Inc. have signed a partnership agreement for the development and optimization of protein bioprocess production and scale-up.

Laval, Quebec (PRWEB) November 19, 2008 -- Med Discovery S.A., a Swiss biotech firm and Laborium Biopharma, a subsidiary of Validapro Biosciences Inc. have signed a partnership agreement for the development and optimization of protein bioprocess production and scale-up.

The first project pursued by the partners is Med Discovery's kallikrein inhibitor MDPK67b, a recombinant therapeutic protein which regulates different biological pathways involved in prostate cancer. The activity of MDPK67b has been validated in animal models of human prostate tumors.

Under the terms of this agreement, Laborium Biopharma will complete the bacterial production process and scale-up, and produce cGMP clinical material required to perform Phase I/IIa clinical trials.

Dr. David Deperthes, President and CEO at Med Discovery, commented: "This ambitious project requires a high level of technical expertise and top quality processes that meet the strictest regulatory standards. This collaboration is crucial, as it provides the platform for the development of our early-phase projects. We believe that Laborium Biopharma represents the ideal partner to help us successfully complete this critical phase of our MDPK67b development program."

Luc Dubois, President of Laborium Biopharma, said: "We are very pleased to collaborate with Med Discovery, a bright and innovative company and are proud of their trust in our capabilities. We will work diligently to help Med Discovery meet the strategic objective of testing its promising therapeutic protein in humans before the end of 2009."

Med Discovery S.A. is a private biopharmaceutical company headquartered in Geneva, Switzerland focusing on treatments for uro-genital cancers. The company is dedicated to the discovery and the development of highly specific protein drugs based on the optimization of natural proteins involved in the regulation of biological pathways. The company is leveraging a strong in-house expertise combined with an international network in clinical urology.

Laborium Biopharma is a private corporation based in the Biotechnology Research Institute of the National Research Council Canada in Montreal, Quebec. This new company is dedicated to the development and optimization of bio-production processes and the cGMP manufacturing of clinical batches of high-potency products.

###

Read the full story at http://www.prweb.com/releases/2008/11/prweb1641134.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Telik Announces New TRAP Drug Discovery Agreement
2. MaxCyte Hosts Live Discussion with Industry Experts on the Challenges in Developing Cell-Based Screening Assays for Drug Discovery
3. TIBCO Speeds Drug Discovery for Chemists
4. Global Drug Discovery Technologies Market to Exceed $57 Billion by 2012, According to a New Report by Global Industry Analysts
5. deCODE Discovery Sheds Light on Risk of the Most Common Form of Skin Cancer
6. Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline
7. The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline
8. Affitech Announces Second Milestone in Roche Antibody Discovery Collaboration
9. ChanTest to Highlight the Worlds Largest Catalog of Ion Channel-Expressing Cell Lines and Discovery Services at Assays & Cellular Targets Conference, Booth 11
10. Assay Designs(TM), Inc. and the Spinal Muscular Atrophy Foundation Announce Collaboration To Accelerate the Discovery of New Therapeutics for Spinal Muscular Atrophy (SMA)
11. Biotechnology & Drug Discovery Markets Push Up Demand for Lab Automation Products, According to a New Report by Global Industry Analysts
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Med Discovery and Laborium Biopharma Sign a Bioprocess Development Partnership Agreement
(Date:7/17/2017)... ... July 17, 2017 , ... ... that has developed and intends both to manufacture and sell reagents used for ... NASDAQ Capital Market. , Headquartered in Sandy, Utah, Co-Diagnostics’ intellectual property and technologies ...
(Date:7/16/2017)... ... July 16, 2017 , ... OHAUS Corporation, a leading ... of its new line of Extreme Environment Shakers today. , Extreme Environment Shakers ... humidity for optimal cell growth such as cell cultures, solubility studies and extraction ...
(Date:7/14/2017)... , ... July 13, 2017 , ... Dr. Joshua Mondlick ... dental implants into his practice, Mondlick Perio, in the Phoenix area. Dr. ... world's first and only FDA cleared laser treatment to re-grow bone and with significantly ...
(Date:7/13/2017)... ... 2017 , ... Thousands of pilots from across the country will visit the ... Pilots come to Muncie to compete in various categories of model flying competition. Each ... in world championships. , RC Pylon (July 14-21): One of the most fun competitions ...
Breaking Biology Technology:
(Date:6/23/2017)... ITHACA, N.Y. , June 23, 2017 ... a leader in dairy research, today announced a new ... help reduce the chances that the global milk supply ... this dairy project, Cornell University has become the newest ... Food Supply Chain, a food safety initiative that includes ...
(Date:5/16/2017)... -- Veratad Technologies, LLC ( www.veratad.com ), an innovative and ... solutions, announced today they will participate as a sponsor ... May 17, 2017, in Washington D.C.,s ... Identity impacts the lives of billions of ... digital world, defining identity is critical to nearly every ...
(Date:4/24/2017)... , April 24, 2017 Janice ... partner with  Identity Strategy Partners, LLP (IdSP) , ... or without President Trump,s March 6, 2017 ... Entry , refugee vetting can be instilled with greater ... (Right now, all refugee applications are suspended by ...
Breaking Biology News(10 mins):